[在接受定期血液透析的患者中对药物消费,多药和营养风险的描述性研究]
Esmeralda Josa Martín1, Guillermina Barril Cuadrado2, Graciela Álvarez García3
1Universidad Complutense de Madrid.
Nutricion hospitalaria
|November 6, 2025
概括
多药性,定义为每天使用≥4种药物,影响超过60%的血液透析患者. 这种高的药物使用与增加的并发症和蛋白质能量浪费综合征 (PEW) 有关,需要更好的药物管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床药房 临床药房
- 老年病的医生 老年病的医生
背景情况:
- 多药在血液透析 (HD) 患者中很常见.
- 在这种人群中,管理多种药物是复杂的.
- 了解药物使用模式对于患者的治疗结果至关重要.
研究的目的:
- 确定HD患者的多药性流行率.
- 按药物治疗组分类药物消费.
- 评估多药与临床/营养结果之间的关联.
主要方法:
- 在两年内对96名患有HD的流行病患者进行了横截面的回顾性研究.
- 收集的数据:社会人口统计,临床,营养,实验室和药物消费.
- 多药性定义为每天≥4种药物;蛋白质能量浪费 (PEW) 通过MIS评估;并发症通过CCI.
主要成果:
- 多种药物的流行率为60.4%.
- 多药性与更高的BMI,转林和度,PEW和CCI相关.
- 最常见的药物:IV铁糖,ESA,抗高血压药,维生素D.
结论:
- 在HD患者中,特别是老年人中,多种药物的高患病率.
- 多药与增加的并发症和营养风险 (PEW) 相关.
- 强调需要跨学科的方法来优化药物使用和管理多病理性HD患者.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
200
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
200
Hemodialysis III: Nursing Management
704
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
704
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
379
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
379
Hemodialysis II: Procedure and Complications
590
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
590
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
225
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
225


